MannKind Co. (MNKD) Forecasted to Post FY2018 Earnings of ($0.71) Per Share


Investment analysts at Zacks Investment Research issued their FY2018 earnings estimates for MannKind in a research report issued on Monday, December 10th. Zacks Investment Research analyst B. Marckx expects that the biopharmaceutical company will earn per share for the year.



from Biotech News